Benchmark Reiterates Buy on Harvard Bioscience, Maintains $4 Price Target

Benchmark analyst Kenneth Bruce reiterates Harvard Bioscience (NASDAQ:HBIO) with a Buy and maintains $4 price target.

byBenzinga Newsdesk

March 10, 2023

1 minute read

Benchmark analyst Kenneth Bruce reiterates Harvard Bioscience (NASDAQ:HBIO) with a Buy and maintains $4 price target.

New Tesla Cybertruck Prototype Spotted: What You Need To Know

By Rachit Vats

Today, 3:53 AM

A new prototype of Tesla Inc’s (NASDAQ: TSLA) hotly-anticipated Cybertruck electric vehicle has been spotted at the Elon Musk-led company’s Fremont factory in California, auto news website Electrek

TSLA

News

Cazoo Announces Conclusion Of Strategic Review Of Its EU Business

By Benzinga Newsdesk

Today, 3:53 AM

Cazoo proposes to wind down operations in mainland Europe to focus on core UK market EU withdrawal ensures business has a plan that removes requirement for further funding UK used car market largest in Europe with

CZOO

Barclays Maintains Equal-Weight on Robinhood Markets, Lowers Price Target to $12

By Benzinga Newsdesk

Today, 3:53 AM

Barclays analyst Ross Sandler maintains Robinhood Markets (NASDAQ:HOOD) with a Equal-Weight and lowers the price target from $42 to $12.

HOOD

Trulieve Opens Medical Marijuana Dispensary In Kissimmee, Florida

By Vuk Zdinjak

Today, 3:53 AM

Trulieve Cannabis Corp. (OTCQX: TCNNF) (CSE: TRUL) is opening of a new medical dispensary in Kissimmee, Florida. Located at 51 N. Doverplum Ave., the doors will open at 9 a.m. on August 4, 2022, with ongoing regular hours of 9 a.m. – 9 p.m. from Monday through Saturday and 10 a.m.

CSE:TRUL

Benchmark Reiterates Buy on Harvard Bioscience, Maintains $4 Price Target

Related Posts

New Tesla Cybertruck Prototype Spotted: What You Need To Know

Cazoo Announces Conclusion Of Strategic Review Of Its EU Business

Barclays Maintains Equal-Weight on Robinhood Markets, Lowers Price Target to $12

Trulieve Opens Medical Marijuana Dispensary In Kissimmee, Florida